000 01615 a2200457 4500
005 20250518053053.0
264 0 _c20200828
008 202008s 0 0 eng d
022 _a1873-2496
024 7 _a10.1016/j.urolonc.2019.06.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorkowska, Edyta Marta
245 0 0 _aUsefulness of droplet digital PCR and Sanger sequencing for detection of FGFR3 mutation in bladder cancer.
_h[electronic resource]
260 _bUrologic oncology
_c12 2019
300 _a907-915 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aDNA Mutational Analysis
_xmethods
650 0 4 _aDNA, Neoplasm
_xgenetics
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aNeoplasm Recurrence, Local
_xdiagnosis
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aReceptor, Fibroblast Growth Factor, Type 3
_xgenetics
650 0 4 _aSensitivity and Specificity
650 0 4 _aUrinary Bladder
_xpathology
650 0 4 _aUrinary Bladder Neoplasms
_xdiagnosis
700 1 _aTraczyk-Borszyńska, Magdalena
700 1 _aKutwin, Piotr
700 1 _aPietrusiński, Michał
700 1 _aJabłonowski, Zbigniew
700 1 _aBorowiec, Maciej
773 0 _tUrologic oncology
_gvol. 37
_gno. 12
_gp. 907-915
856 4 0 _uhttps://doi.org/10.1016/j.urolonc.2019.06.010
_zAvailable from publisher's website
999 _c29971046
_d29971046